Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regenxbio

9.61
+1.2514.95%
Post-market: 9.45-0.1600-1.66%17:59 EDT
Volume:1.91M
Turnover:17.92M
Market Cap:482.04M
PE:-3.10
High:9.78
Open:8.42
Low:8.32
Close:8.36
Loading ...
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Sep 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 03, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report